Incidence & Clinical Progression of Asymptomatic PICC-Related Thrombosis

Status Completed

Clinical Trial Summary

In this prospective cohort study, the investigators evaluated the incidence of superficial vein thrombosis, deep vein thrombosis, and fibroblastic sleeve formation in solid cancer patients undergoing chemotherapy. The study aimed to shed light on the clinical progression of venous thrombosis in cancer patients with central venous catheters, with a particular focus on certain cancer types associated with a higher risk of venous thromboembolism (VTE). The investigators believe that such findings hold significant clinical relevance as a substantial portion of the study population was affected by pancreatic cancer, a cancer type known to carry a high risk of thrombotic events. This research adds valuable insights into understanding asymptomatic PICC-related thrombosis in this specific subgroup of cancer patients, which can aid in developing effective management strategies for venous access in this challenging population. The study employed an ultrasound-guided approach for follow-up at 30 and 90 days after catheter insertion, enabling us to detect and treat asymptomatic PICC-VTE in a timely manner. Identifying independent risk factors for catheter-related thrombosis, including age and cancer type, has further enhanced the clinical applicability of our findings.

Clinical Trial Description

Managing venous access in cancer patients is challenging, and peripherally inserted central catheter-ports (PICC-ports) have emerged as a promising option for safety and efficacy. However, understanding the clinical progression of venous thrombosis in cancer patients with central venous catheters remains limited, especially in certain cancer types associated with a higher risk of venous thromboembolism (VTE). In this prospective cohort study of solid cancer patients receiving chemotherapy, the investigators will evaluate the incidence of superficial vein thrombosis, deep vein thrombosis, and fibroblastic sleeve formation through ultrasound follow-up at 30 and 90 days after catheter insertion. The investigators will analyze clinical factors associated with PICC-related VTE (PICC-VTE) and compare incidence rates between PICC-ports and traditional PICCs. Ultrasound follow-up is valuable for detecting asymptomatic PICC-VTE, enabling timely and effective initiation of therapy, especially in elderly patients and those with high-risk thrombotic cancers. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05966909
Study type	Observational
Source	Azienda Ospedaliera Universitaria Integrata Verona
Contact
Status	Completed
Phase
Start date	January 1, 2020
Completion date	December 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04454970` - Safe Access for Bladder Entry in Transgender Men Following Penile Reconstruction	N/A
Recruiting	`NCT05860231` - Comparative Study Between Foley and T-Control® Catheter in Patients With Long-term Catheterization	N/A
Recruiting	`NCT05334225` - Assessing the Knowledge and Self-confidence of Healthcare Workers to Perform Transurethral Catheterization: A Multicenter Survey
Recruiting	`NCT04140916` - Comparison of Two Peripheral Inserted Intravenous Catheters	N/A
Not yet recruiting	`NCT06019897` - Impact of Tubing Colonization on the Incidence of Central Venous Catheter Infection
Completed	`NCT04811430` - Efficiency, and Emergency Department Nurse Preference Between 2 Methods of Visualization: A Pilot Study
Recruiting	`NCT05741866` - Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs)	N/A
Recruiting	`NCT03924583` - Duplex Ultrasonography Performed by Nurses
Completed	`NCT04683302` - 3D Guided Internal Jugular Vein Catheterization	N/A
Completed	`NCT04314050` - Comparison of Tramadol and Dexmedetomidine in the Prevention of Urinary Catheter Discomfort in Urinary Surgery	N/A
Completed	`NCT04814745` - Intrathecal Morphine for Radical Robot Assisted Prostatectomy (TORNADO)	N/A
Completed	`NCT05948878` - An Innovative Taping Technique for Improved Intravenous (IV) Catheter Securement	N/A
Recruiting	`NCT05931887` - Evaluation of the Novel Silq ClearTract Catheter in Patients With Chronic Urinary Retention	N/A
Completed	`NCT05130762` - An Observational Study to Evaluate BD PureHub™ Disinfecting Cap Use on Needle-Free Connectors
Recruiting	`NCT05284422` - Effect of Ultrasound-guided Insertion on Peripheral Catheters Related Complications.	N/A
Completed	`NCT04772209` - Comparison of Effectiveness and Complications of Catheter Lock Solutions in Non-tunneled Hemodialysis Catheters	N/A
Recruiting	`NCT06109584` - Verification of the Correct Insertion of a Central Venous Catheter	N/A
Recruiting	`NCT05860634` - Urinary Catheter Self-Discontinuation After Urogynecology Surgery	N/A
Completed	`NCT03955653` - Fluoroscopic-Guided Micropuncture Technique for Common Femoral Artery Access	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Incidence and Clinical Progression of Asymptomatic PICC-Related Thrombosis in Solid Cancer Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms